Nemaura Medical, manufacturer of the sugarBEAT continuous glucose monitor sold in the UK through MySugarWatch, and the Miboko body worn glucose sensor, has just received
We chat to Chris Avery at Nemaura Medical about how we report blood glucose levels and HbA1c. By Sue Marshall I was five when I
Nemaura Medical is bringing the soon-to-launch sugarBEAT sensor to the UK. Bucking the trend for sensors aimed at people on insulin, the company’s intention is
A new digital healthcare subscription service, proBEAT, aimed at people with Type 2 diabetes and pre-diabetes, is preparing for launch in the US. The service
The SugarBeat CGM is being repurposed as a continuous temperature monitor (CTM) to help diagnose fevers in potential cases of COVID-19. The device, by Nemaura
Nemaura Medical and Changing Health have announced a partnership to provide award-winning diabetes behavioural change services. The companies Will join forces to provide innovative digital
Nemaura Medical is a medical technology company focused on the development of SugarBEAT as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use
Nemaura has developed predictive algorithms to support alarm functions in its wearable SugarBeat glucose monitoring system. The British company’s device has alarm functionality that can
Nemaura Medical, based in Loughborough, UK, received European regulatory (CE) approval, and following improvements to the user interface and reduction in size of the device,
